Bio Gate AG Share Price BOERSE MUENCHEN
Equities
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
||
- EUR | - |
2023 | Bio-Gate AG Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
2023 | Bio-Gate AG Signs LOI with North American Medical Device Manufacturer for Trauma Implants | CI |
Sales 2023 | 7.25M 7.76M 646M | Sales 2024 * | 8.21M 8.79M 732M | Capitalization | 9.15M 9.8M 815M |
---|---|---|---|---|---|
Net income 2023 * | - | Net income 2024 * | - | EV / Sales 2023 | 1.23 x |
Net cash position 2023 * | - 0 0 | Net cash position 2024 * | - 0 0 | EV / Sales 2024 * | 1.11 x |
P/E ratio 2023 * |
-
| P/E ratio 2024 * |
-
| Employees | - |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 48.3% |
Managers | Title | Age | Since |
---|---|---|---|
Marc Lloret-Grau
CEO | Chief Executive Officer | - | 08/12/08 |
Thomas Konradt
PRN | Corporate Officer/Principal | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Volker Rofalski
BRD | Director/Board Member | 54 | 01/12/01 |
Karl Richter
CHM | Chairman | - | - |
Volker Alt
BRD | Director/Board Member | - | - |
1st Jan change | Capi. | |
---|---|---|
-3.43% | 184B | |
-1.81% | 107B | |
-4.15% | 67.78B | |
+1.43% | 50.66B | |
+11.60% | 47.64B | |
+2.98% | 41.12B | |
+3.03% | 26.3B | |
+3.21% | 26.04B | |
+15.38% | 25.4B |